Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type II cuticular Hb2 (KRT82), is a member of the type II hair keratin family of intermediate filament proteins that are basic structural components of hair and nail fibers[1][6][7][8]. KRT82 is predominantly expressed in the cuticle of human hair and functions by heterodimerizing with type I keratins to form the intermediate filament network necessary for the mechanical strength and structure of hair and nails[1][6][7][5]. Type II hair keratins, including KRT82, cluster in a region on chromosome 12 and are among the set of “hard” or hair keratins expressed specifically in hair cortex and cuticle cells during hair shaft formation[4]. Mutations or dysregulation of hair keratins can result in structural hair disorders, but KRT82 itself is not established as a common therapeutic drug target, disease biomarker, or safety concern in clinical or pharmacological contexts[1][6][7][8][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type II cuticular Hb2 (KRT82).